![Michal Roytman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michal Roytman
Nessuna posizione attualmente
Profilo
Michal Roytman worked as a Director of Products Sales & Marketing at CollPlant Biotechnologies Ltd.
from 2020 to 2022.
Prior to that, he was a Development Manager at NeuroDerm Ltd.
from 2016 to 2017 and a Product Manager at OCON Medical Ltd.
from 2017 to 2018.
Mr. Roytman holds a graduate degree from Technion-Israel Institute of Technology and an MBA from Bar-Ilan University.
Precedenti posizioni note di Michal Roytman
Società | Posizione | Fine |
---|---|---|
OCON Medical Ltd.
![]() OCON Medical Ltd. Medical/Nursing ServicesHealth Services OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel. | Corporate Officer/Principal | 01/07/2018 |
NEURODERM LTD | Corporate Officer/Principal | 01/11/2017 |
COLLPLANT BIOTECHNOLOGIES LTD. | Vendite & Marketing | - |
Formazione di Michal Roytman
Technion-Israel Institute of Technology | Graduate Degree |
Bar-Ilan University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
COLLPLANT BIOTECHNOLOGIES LTD. | Health Technology |
Aziende private | 2 |
---|---|
OCON Medical Ltd.
![]() OCON Medical Ltd. Medical/Nursing ServicesHealth Services OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel. | Health Services |
NeuroDerm Ltd.
![]() NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
- Borsa valori
- Insiders
- Michal Roytman